BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12002706)

  • 21. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
    Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
    Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
    Dierickx LO; Everaert H; Deron P; Voordeckers M; Lahoutte T; Bossuyt A
    Nucl Med Commun; 2003 Jun; 24(6):633-41. PubMed ID: 12766598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
    Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
    J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
    De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
    Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F-18-2-fluoro-2-deoxyglucose positron emission tomography compared to technetium-99m hexakis-2-methoxyisobutyl isonitrile single photon emission chest tomography in the diagnosis of indeterminate lung lesions.
    Santini M; Fiorelli A; Vicidomini G; Laperuta P; Busiello L; Rambaldi PF; Mansi L; Rotondo A
    Respiration; 2010; 80(6):524-33. PubMed ID: 20881375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.
    Altehoefer C; Kaiser HJ; Dörr R; Feinendegen C; Beilin I; Uebis R; Buell U
    Eur J Nucl Med; 1992; 19(5):334-42. PubMed ID: 1612095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
    Martin WH; Jones RC; Delbeke D; Sandler MP
    Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer.
    Grünwald F; Menzel C; Bender H; Palmedo H; Willkomm P; Ruhlmann J; Franckson T; Biersack HJ
    Thyroid; 1997 Jun; 7(3):327-35. PubMed ID: 9226199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG-PET, 99mtc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties.
    Van Acker F; Nuyts J; Maes A; Vanquickenborne B; Stuyck J; Bellemans J; Vleugels S; Bormans G; Mortelmans L
    Eur J Nucl Med; 2001 Oct; 28(10):1496-504. PubMed ID: 11685492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy.
    Soler C; Beauchesne P; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
    Eur J Nucl Med; 1998 Dec; 25(12):1649-57. PubMed ID: 9871097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
    Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB
    Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas?
    Moka D; Eschner W; Voth E; Dietlein M; Larena-Avellaneda A; Schicha H
    Eur J Nucl Med; 2000 May; 27(5):485-9. PubMed ID: 10853801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99mTc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy.
    Furuta M; Nozaki M; Kawashima M; Iimuro M; Kitazumi Y; Okayama A; Natsui S; Hamashima Y; Nagao K
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):982-7. PubMed ID: 12734691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of myocardial washout of
    Suzuki M; Izawa Y; Fujita H; Miwa K; Takahashi Y; Toh H; Toba T; Fujiwara S; Hashimura H; Kono AK; Hirata KI
    Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
    Roh JL; Pae KH; Choi SH; Kim JS; Lee S; Kim SB; Nam SY; Kim SY
    Eur J Surg Oncol; 2007 Aug; 33(6):790-5. PubMed ID: 17306956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.